Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

269.67
Delayed Data
As of Dec 09
 +1.15 / +0.43%
Today’s Change
240.03
Today|||52-Week Range
343.87
-20.29%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

5 Stocks That Got Run Over By the Trump Train
Dec 09 / Zacks.com - Paid Partner Content
Biotech & Pharma ETFs to Suffer in 2017 Too?
Dec 08 / Zacks.com - Paid Partner Content
5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices
Dec 08 / Zacks.com - Paid Partner Content
Stocks Lose Highs, Dow Still on Track For Record
Dec 08 / TheStreet.com - Paid Partner Content
Dow, S&P 500 and Nasdaq Post New Closing Highs as Record-Breaking Run Continues
Dec 08 / TheStreet.com - Paid Partner Content
Don't Blame Trump for Biotechs' Retreat
Dec 08 / TheStreet.com - Paid Partner Content

Performance

1 month-5.52% 3 years+6.88%
3 months-3.34% 5 years+21.74%
1 year-17.02% Since inception+6.60%
Data through 12/10/2016

Quote Details

Previous close$268.52
Open day’s range268.25 – 275.39
Net asset value (NAV)269.45 (12/09/2016)
Daily volume2,197,977
Average volume (3 months)1,692,437
Data as of 4:00pm ET, 12/09/2016

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+21.74%+20.19%
Expense Gross exp ratio0.47%1.31%
Risk 5 year sharpe ratio0.991.11
Net assets$7.9B$2.9B
Average market cap$15.5B$31.6B
Average P/E19.918.6
Dividend / Share--0.26%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CELG Celgene9.28%
BIIB Biogen8.04%
GILD Gilead Sciences7.86%
AMGN Amgen7.08%
REGN Regeneron Pharmaceuticals7.07%
ALXN Alexion Pharmaceuticals Inc4.07%
MYL Mylan NV3.61%
VRTX Vertex Pharmaceuticals Inc3.61%
INCY Incyte Corp3.55%
ILMN Illumina Inc3.31%

Search for Jobs